Creating diversity, equity, inclusion, and access in cancer clinical research: Drive rank and Drive score.

Abstract

e13636 Background: The inequalities in improving cancer mortality rates in the United States can be ascribed to treatment disparities that are largely due to unequal access to clinical trials in cancer care, resulting in adverse clinical and economic effects. D.R.I.V.E is a five-step strategy for promoting and improving DEIA in clinical trials for minority patients based on the following steps. Methods: Appointing a clinical trial Diversity Officer, creating a RANK SCORE based on minority enrollment, Individual diversity plan, Verification of study diversity, and Elevate and Enhanced training of minority investigators and research team members. Results: Global Performance Indicators (GPIs), which rate and rank states relative to one another, shape decisions. Rankings should be reported by authors and required for publication in peer-reviewed journals and should be included in journal impact factor assessment. Conclusions: DRIVE aims to use these strategies to correct inequalities and promote the overall health of mankind, using proven principles and techniques to create meaningful improvements in cancer care and outcomes. DRIVE RANK), based on the achievement of minority participant representation relative to the epidemiology of disease, is an informational tool to evaluate DEIA efforts and provide a readily accessible measurement of the applicability of clinical data to all patient subgroups with the potential to force positive changes to promote DEIA and the health of mankind. We propose a ranking of 0-5 for diversity (Table). Establish a corporate ranking system (DRIVE SCORE) based on the diversity of clinical data from the totality of studies of the company to inform the choice of ethical investors. Studies will be ranked at the next lower rank if all criteria for next higher rank are not reached.[Table: see text]